National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

pyrimethamine
A synthetic derivative of ethyl-pyrimidine with potent antimalarial properties. Pyrimethamine is a competitive inhibitor of dihydrofolate reductase (DHFR). DHFR is a key enzyme in the redox cycle for production of tetrahydrofolate, a cofactor that is required for the synthesis of DNA and proteins. This agent is often used in combination with other antimalarials for the treatment of uncomplicated falciparum malaria. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

US brand name:Daraprim



Previous:PVA microporous hydrospheres/doxorubicin hydrochloride, pyrazine diazohydroxide, pyrazofurin, pyrazoloacridine, pyridoxine hydrochloride
Next:pyroxamide, pyruvate kinase inhibitor TLN-232, QS21, Quadramet, quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov